Tyrosine-kinase inhibitors (TKI) in metastatic kidney cancer (mKC) treatment.

被引：0
|
作者：
Vladimirova, Liubov Yu [1 ]
Kit, Oleg Ivanovich [1 ]
Popova, Irina L. [1 ]
Abramova, Natalya A. [1 ]
机构：
[1] Rostov Sci Res Inst Oncol, Rostov Na Donu, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15546
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15546
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Protein tyrosine kinase inhibitors in cancer treatment
    Traxler, PM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (06) : 571 - 588
  • [42] Second-generation tyrosine-kinase inhibitors and combinations: perspectives
    Coiteux, V.
    ONCOLOGIE, 2012, 14 (10-11) : 601 - 605
  • [43] Tyrosine-kinase inhibitors-new standard for NSCLC therapy
    Saijo, Nagahiro
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (11) : 618 - 619
  • [44] Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
    Florian Janisch
    Thomas Klotzbücher
    Phillip Marks
    Christina Kienapfel
    Christian P. Meyer
    Hang Yu
    Constantin Fühner
    Tobias Hillemacher
    Keiichiro Mori
    Hadi Mostafei
    Shahrokh F. Shariat
    Margit Fisch
    Roland Dahlem
    Michael Rink
    World Journal of Urology, 2021, 39 : 2977 - 2985
  • [45] Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
    Janisch, Florian
    Klotzbuecher, Thomas
    Marks, Phillip
    Kienapfel, Christina
    Meyer, Christian P.
    Yu, Hang
    Fuehner, Constantin
    Hillemacher, Tobias
    Mori, Keiichiro
    Mostafei, Hadi
    Shariat, Shahrokh F.
    Fisch, Margit
    Dahlem, Roland
    Rink, Michael
    WORLD JOURNAL OF UROLOGY, 2021, 39 (08) : 2977 - 2985
  • [46] Anaplastic lymphoma kinase (ALK) inhibitors for cancer treatment.
    Lee, Kvvangho
    Kim, Hyoung Rae
    Cho, Sung Yun
    Jung, Hee Jung
    Ha, Jae D.
    Yun, Chang-Soo
    Kim, Pilho
    Park, Chi Hoon
    Lee, Chong Ock
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [47] Tyrosine-Kinase Inhibitors for Treatment in Hemodialysis Patients on Kidney Transplant Waiting List. Comment on: Nakai et al.
    Comai, Giorgia
    Cappuccilli, Maria
    Cianciolo, Giuseppe
    La Manna, Gaetano
    THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (05) : 515 - 516
  • [48] A SWISS RETROSPECTIVE LUNG CANCER SURVEY ON DOSE CHANGE AND DURATION OF TREATMENT WITH ORAL TYROSINE KINASE INHIBITORS (TKI)
    Cathomas, R.
    von Rohr, A.
    Hosli, P.
    Giger, M.
    Malz, S.
    Betticher, D.
    LUNG CANCER, 2009, 64 : S55 - S55
  • [49] Tyrosine kinase: implications in tumorigenesis and new avenues for cancer treatment.
    Peyrade, F
    Taillan, B
    Lebrun, C
    Baron, V
    Dujardin, P
    REVUE DE MEDECINE INTERNE, 1998, 19 (05): : 366 - 372
  • [50] Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey
    Masini, Cristina
    Sabbatini, Roberto
    Porta, Camillo
    Procopio, Giuseppe
    Di Lorenzo, Giuseppe
    Onofri, Azzurra
    Buti, Sebastiano
    Iacovelli, Roberto
    Invernizzi, Roberta
    Moscetti, Luca
    Aste, Maria Giuseppina
    Pagano, Maria
    Grosso, Federica
    Manenti, Anna Lucia
    Ortega, Cinzia
    Cosmai, Laura
    Del Giovane, Cinzia
    Conte, Pier Franco
    BJU INTERNATIONAL, 2012, 110 (05) : 692 - 698
12345